Key result
Beta-blocker therapy is being evaluated in a Cochrane Review protocol to assess its long-term efficacy and safety for preventing aortic dissection in patients with Marfan's syndrome.
Key points are not available for this paper at this time.
This is a protocol for a Cochrane Review (Intervention). The objectives are as follows: To assess the long‐term efficacy and safety of beta‐blocker therapy in people with Marfan's syndrome.
No takes yet. Share an insight, caveat, or question.
Koo et al. (2014) studied this question. Beta-blocker therapy is being evaluated in a Cochrane Review protocol to assess its long-term efficacy and safety for preventing aortic dissection in patients with Marfan's syndrome.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: